Trend Results : Cancer Center


Blog Post Results (1-20 of 2984)

FILTER RESULTS

Crawfish for Cancer uses art to spread the word

New York is known for a lot of things: bagels, Rockefeller Center, the Yankees, and even its newest transplant, Taylor Swift. As multifaceted as the Big Apple is, however, there are some time-honored Southern customs that fade away across the Mason-Dixon Line.… [ Read more ] [ Subscribe to the comments on this story ]

Eligible for Breast Conserving Therapy, Many Still Choose Mastectomy

New research led by Brigham and Women's Hospital in collaboration with the UNC Lineberger Comprehensive Cancer Center finds that breast-conserving therapy - or the removal of less breast tissue via a lumpectomy - was successful in more than 90 percent of the women who became eligible for this procedure after treatment with chemotherapy. Show More Summary

Rutgers Cancer Institute of New Jersey Nurses Design Oncology Nursing Fellowship Program

Responding to tremendous clinical growth at their center and the desire for nursing professionals to be well versed in oncology practice, nurses at Rutgers Cancer Institute of New Jersey developed a specialized Advanced Practice Nursing Fellowship Program to address these needs. Show More Summary

Modified Citrus Pectin Enhances Radiation Therapy in Prostate Cancer Treatment

Scientists at Tel Aviv Medical Center, Israel, have found that oral modified citrus pectin (MCP) enhances the anti-cancer and anti-metastatic effects of radiation therapy in the treatment of androgen-independent (AI) aggressive prostate cancer cells. Results were presented today at the American Association for Cancer Research (AACR) Annual Meeting 2015.

Take lots of dietary supplements? You may have increased cancer risk, says new meta-study.

3 days agoHumor / odd : Boing Boing

Dr. Tim Byers, who is the director for cancer prevention and control at the University of Colorado Cancer Center, conducted a meta-analysis of 12 trials involving more than 300,000 people, over 12 years -- and found that high doses of certain vitamin supplements were linked to increased odds that a person would develop certain kinds of cancer. Read the rest

Most Cancer Patients Want Tumor Profiling, Even if It Reveals Other Genetic Risks

Most cancer patients would opt for tumor profiling even if the test revealed that they or their families were at risk for other genetic diseases, according to a Yale Cancer Center study. The findings were presented April 21 at the American Association for Cancer Research Annual Meeting 2015 in Philadelphia.

Re-Engineering Lupus Into a Cancer Killer

Researchers from the Yale Cancer Center and the Veterans Affairs Greater Los Angeles Healthcare System have devised a way to re-engineer lupus antibodies to turn them into potential cancer killers. Findings from recent research were presented April 21 at the American Association for Cancer Research Annual Meeting 2015 Philadelphia.

Dietary Supplements Shown to Increase Cancer Risk

While dietary supplements may be advertised to promote health, a forum at the American Association for Cancer Research (AACR) Annual Meeting 2015 by University of Colorado Cancer Center investigator Tim Byers, MD, MPH, describes research showing that over-the-counter supplements may actually increase cancer risk if taken in excess of the recommended dietary amount.

MD Anderson Study Seeks Earlier Ovarian Cancer Detection

Successful ovarian cancer treatment often relies on catching it early. A study at The University of Texas MD Anderson Cancer Center may help point to a new method for women at risk.

Oral Milk Thistle Extract Stops Colorectal Cancer Stem Cells From Growing Tumors

"It's very simple: tumors from mice that were initially fed silibinin had fewer cancer stem cells, were smaller, had lower metabolisms and showed decreased growth of new blood vessels," says University of Colorado Cancer Center researcher.

Yale Joins Lung Cancer Dream Team

Yale Cancer Center will join a group of prominent cancer research and treatment institutions in a new Stand Up To Cancer (SU2C) - American Cancer Society $20 million Dream Team to combat lung cancer.

Breast Tumor Stiffness and Metastasis Risk Linked by Molecule's Movement

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and poor prognosis. The study may inspire new approaches to predicting patient outcomes and halting tumor metastasis.

How Statistics Can Capture the Unique Fingerprint of Cancer

KU Cancer Center researcher is using genomic, transcriptomic and epigenomic data to determine cancer molecular subtypes.

Clinical trial for personalized kidney cancer vaccine

A research center has enrolled its first patient in a phase 3 clinical trial that uses a person’s own kidney cancer cells to make a vaccine tailored to kill those cells.

Comprehensive Genomic Tumor Profiling Comes to UC Davis

The UC Davis Comprehensive Cancer Center and the Department of Pathology and Laboratory Medicine have entered into a collaboration with Foundation Medicine, a leading molecular information company. The collaboration brings comprehensive...Show More Summary

Tumor Genome Sequencing Shows the Most Frequently Altered Gene in Bladder Cancer: TERT

At AACR, joint study by NCI and University of Colorado Cancer Center shows TERT is most commonly mutated gene in bladder cancer.

Clinical Trial Offers Patient 'Best Shot' at Fighting Kidney Cancer

The pain Anne Holmes felt in her arm was actually kidney cancer that had spread. She joined a phase 3 clinical trial that recently opened at the UNM Cancer Center. The trial tests a new approach that strips the invisibility cloak from spreading kidney cancer cells; it will use Holmes' own cells to create a vaccine tailored for her cancer cells.

UNM Cancer Center Opens International Clinical Trial for Personalized Kidney Cancer Vaccine

The University of New Mexico Cancer Center enrolled its first patient in a phase 3 clinical trial that uses a person's own kidney cancer cells to make a vaccine tailored to kill those cells.

A Tale of Two Hospitals

Cancer Hospital in final stages of construction at the University of Florida. (Photo credit: Wikipedia) Let's build two large hospitals in one lucky city. One of them will be a state-of-the-art medical center offering evidence-based medicine from a collection of talented physicians, nurses, and other trained professionals. Show More Summary

New Combination of Immunotherapy Drugs is Safe, Shrinks Tumors in Metastatic Melanoma Patients

Once again, researchers at Penn's Abramson Cancer Center have extended the reach of the immune system in the fight against metastatic melanoma, this time by combining the checkpoint inhibitor tremelimumab with an anti-CD40 monoclonal antibody drug.

Copyright © 2015 Regator, LLC